APCER Pharma announced that in the past three months it has further expanded its customer base and operations. APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies. Key events during this time period included:

“What makes APCER truly different is our deep knowledge pool and on-the-ground operations in North America, Asia and Europe, enabling us to provide crisp, relevant solutions that are extremely cost effective and at a global scale, where necessary.”

Six new customers: In the past three months APCER entered into agreements to manage international pharmacovigilance strategies and programs for six global pharmaceutical companies with multi-country operations. APCER’s activities for the companies, which run the gamut of therapies, involve:

·    Risk Management, Compliance Services

·    Adverse Event Intake, Processing and Reporting

·    Medical Information Response Center

·    Signal Detection and Aggregate Report Writing

Office Expansion: APCER doubled its office space at all of its operations – US, Europe and Asia.

Thought Leadership: CenterWatch published an insightful interview with APCER President and CEO Suneet Walia. Prior to that, more than 250 professionals in the life sciences related industries attended APCER’s webinar on 2010 FDA drug safety and pharmacovigilance initiatives. Additionally, top industry publication Pharmaceutical Executive Europe published APCER executive Michael Reynolds’ insightful article outlining new approaches for managing drug safety.

Suneet Walia explained, “What makes APCER truly different is our deep knowledge pool and on-the-ground operations in North America, Asia and Europe, enabling us to provide crisp, relevant solutions that are extremely cost effective and at a global scale, where necessary.”

Source：web of pharmaceutical news